Pharmaceutical companies are working to step into the pneumonia vaccine market, which Pfizer currently dominates and is forecasted to generate $10 billion by 2028, The Wall Street Journal reported Oct. 31.
Read the full post on Becker's Hospital Review - Healthcare News
